期刊文献+

载脂蛋白A5低甘油三酯效应的机制 被引量:1

下载PDF
导出
摘要 载脂蛋白A5是降低血浆甘油三酯水平最为显著的因子之一,高甘油三酯血症是冠状动脉粥样硬化性心脏病的独立危险因子,因而成为近年来医学研究热点之一。本文简要介绍了载脂蛋白A5的表达调控机制,重点阐述了载脂蛋白A5在降低血浆甘油三酯水平中的作用,为治疗高甘油三酯血症、心血管疾病等人类重大疾病提供新的方向和思路。
出处 《中国动脉硬化杂志》 CAS CSCD 2007年第12期964-968,共5页 Chinese Journal of Arteriosclerosis
基金 国家自然科学基金资助项目(30571335 30771553) 浙江省科技厅重大科技攻关项目(2005C12005-01)
  • 相关文献

参考文献31

  • 1Pennacchio LA, O livier M, Hubacek JA, et al. An apolipoprotein influencing triglycerides in humans and m ice revealed by comparative sequencing [J] .Science. 2001, 294 :169-173 . .
  • 2van der Vliet HN,Sammels MG,Leegwater AC,Levels JH,Reitsma PH,Boers W,et al.Apolipoprotein A-V:a novel apolipoprotein associated with an early phase of liver regeneration[J].J Biol Chem,2001, 276 (48) : 44 512-520.
  • 3龙骁,李向平.载脂蛋白A5研究现状[J].中国动脉硬化杂志,2006,14(9):826-828. 被引量:4
  • 4李国平,陈保生.载脂蛋白家族新成员——载脂蛋白A5基因研究进展[J].中国动脉硬化杂志,2004,12(2):229-232. 被引量:10
  • 5Talmud PJ. Rare APOA5 mutations-Clinical consequences,metabolic and func-tional effects[J] .Atherosclerosis, 2007, 194 (2) :287-292 . .
  • 6Sun GT,Bi N,Li GP,Zhu XW,Zeng WW,Wu G,et al. Identification oflipid binding and lipoprotein lipase activation domains of human apoAV[J] .JChem Phys Lip, 2006, 143 (1-2) :22-28 . .
  • 7Prieur X,Coste H,and Rodírguez JC. The human apolipoprotein AV gene isregulated by peroxisomeproliferator-activated receptorα-and contains a novel farne-soid X-activated receptor response element[J] .J Biol Chem, 2003, 278 (28) :25468-480 . .
  • 8N oc VD,Gervois P,Jakel H,Nowak M,Baugé E,Dehondtet H,et al. Apo-lipoprotein A5,a crucial determinant of plasma triglyceride levels,is highly re-sponsive to peroxisome proliferator-activated receptorαactivators[J] .J BiolChem, 2003, 278 (20) :17982-985 . .
  • 9Schultze AE,Alborn WE,Newton RK,and Konrad RJ.Administration of a PPAR α agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V/apolipoprotein C-III ratio[J].J Lipid Res,2005, 46 (8): 1 591-595.
  • 10Benoit G,Cooney A,Giguere V,Ingraham H,Lazar M,Muscat G,et al. International Union of Pharmacology LXVI.Orphan Nuclear Receptors[J] .Pharmacol Rev, 2006, 58 (4) :798-836 . .

二级参考文献33

  • 1毕楠,鄢盛恺,李国平,尹志农,薛红,吴刚,陈保生.冠心病患者载脂蛋白A5和载脂蛋白C3基因多态性的研究[J].中华心血管病杂志,2005,33(2):116-121. 被引量:47
  • 2曾武威,吕新跃,陈保生.载脂蛋白E基因多态性与高脂血症的相关性研究[J].中国动脉硬化杂志,1996,4(3):185-189. 被引量:12
  • 3Van der Vliet HN,Sammels MG,Leegwater AC,Levels JH,Reitsma PH,Boers W,et al.Apolipoprotein A-V:a novel apolipoprotein associated with an early phase of liver regeneration.J Biol Chem,2001,276:44 512-520
  • 4Pennacchio LA,Olivier M,Hubacek JA,Cohen JC,Cox DR,Fruchart JC,et al.An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.Science,2001,294:169-173
  • 5XA-Vier Prieur,Hervé Coste,Joan C Rodríguez.The human apolipoprotein A5 gene is regulated by peroxisome proliferator-activated receptor-alpha and contA1ns a novel farnesoid X-activated receptor response element.J Biol Chem,2003,278:25 468-480
  • 6Van der Vliet HN,Schaap FG,Levels JH,Ottenhoff R,Looije N,Wesseling JG,et al.Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice.Biochem Biophys Res Commun,2002,295:1 156-159
  • 7Seda O,Sedova L.New apolipoprotein A-V:comparative genomics meets metabolism.Physiol Res,2003,52:141-146
  • 8Endo K,Yanagi H,Araki J,Hirano C,Yamakawa-Kobayashi K,Tomura S.Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren.Hum Genet,2002,111:570-572
  • 9Nabika T,Nasreen S,Kobayashi S,Masuda J.The genetic effect of the apoprotein A-V gene on the serum triglyceride level in Japanese.Atherosclerosis,2002,165:201-204
  • 10Martin S,Nicaud V,Humphries SE,Talmud PJ.Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges.Biochim Biophys Acta,2003,1 637:217-225

共引文献11

同被引文献12

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部